Loading...

Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers

Purpose: To demonstrate the safety and feasibility of leveraging therapeutic antibodies for surgical imaging. Procedures: We conducted two phase I trials for anti-epidermal growth factor receptor antibodies cetuximab-IRDye800CW (n=12) and panitumumab-IRDye800CW (n=15). Adults with biopsy-confirmed h...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Theranostics
Main Authors: Gao, Rebecca W., Teraphongphom, Nutte, de Boer, Esther, van den Berg, Nynke S., Divi, Vasu, Kaplan, Michael J., Oberhelman, Nicholas J., Hong, Steven S., Capes, Elissa, Colevas, A. Dimitrios, Warram, Jason M., Rosenthal, Eben L.
Format: Artigo
Sprog:Inglês
Udgivet: Ivyspring International Publisher 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928904/
https://ncbi.nlm.nih.gov/pubmed/29721094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.24487
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!